MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00277-024-05877-8

Медицинская библиотека · Annals of hematology · 2024

Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study.

Ebeid Fatma Soliman Elsayed, Aly Nihal Hussien, Shaheen Naglaa Mohammed, Abdellatif Samah Mohammed Ahmed, Okba Ahmed Ashraf Mahmoud, Gad Nada Ayman, Makkeyah Sara Mostafa

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

To evaluate the safety and efficacy of L-glutamine in reducing vaso-occlusive crisis (VOC) and improving cerebral arterial blood flow in children with sickle cell disease (SCD). This is an interventional randomized controlled trial that recruited sixty SCD patients, aged 9.2 ± 3.7 years, who had at least two VOCs during the last 12 months and on a stable dose of hydroxyurea. They were randomly assigned in a 1:1 ratio to receive glutamine (0.3 gm/kg/dose/12h) orally for 24 weeks or the standard of care (SOC). All patients had VOCs in the last year > 3, those on glutamine had a higher number of VOCs and hospitalization for VOC in the last year. There was a decreasing trend in the number, severity, and hospitalization of VOC and a significantly lower cumulative number of VOCs and hospitalizations in the glutamine group than in SOC (p = 0.008, p < 0.001 respectively). Time-averaged mean maximum velocity for the glutamine group had a marginal increase in both middle cerebral arteries, all values remained normal within a normal range, and in both internal carotid arteries, values increased from abnormally low to normal ranges at week 24. Glutamine reduced the number of VOCs and severity and may have a potentially favorable impact on the cerebral arterial flow velocities.

Для цитирования: Ebeid Fatma Soliman Elsayed, Aly Nihal Hussien, Shaheen Naglaa Mohammed, Abdellatif Samah Mohammed Ahmed, Okba Ahmed Ashraf Mahmoud, Gad Nada Ayman, Makkeyah Sara Mostafa. Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study.. Annals of hematology. 2024. DOI: 10.1007/s00277-024-05877-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.